Bookmark Saya

DOAJ Open Access 2023

Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma

Domenica Lorusso Domenica Lorusso Romano Danesi Laura Deborah Locati Laura Deborah Locati +11 lainnya
Lihat Sumber DOI

Topik & Kata Kunci

Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Penulis (16)

D

Domenica Lorusso

D

Domenica Lorusso

R

Romano Danesi

L

Laura Deborah Locati

L

Laura Deborah Locati

G

Gianluca Masi

G

Gianluca Masi

U

Ugo De Giorgi

A

Angiolo Gadducci

S

Sandro Pignata

R

Roberto Sabbatini

A

Antonella Savarese

G

Giorgio Valabrega

C

Claudio Zamagni

N

Nicoletta Colombo

N

Nicoletta Colombo

Format Sitasi

APA MLA BibTeX
Lorusso, D., Lorusso, D., Danesi, R., Locati, L.D., Locati, L.D., Masi, G. et al. (2023). Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. https://doi.org/10.3389/fonc.2023.1232476

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.3389/fonc.2023.1232476
Informasi Jurnal
Tahun Terbit
2023
Sumber Database
DOAJ
DOI
10.3389/fonc.2023.1232476
Akses
Open Access ✓